Indo US Bio-Tech Ltd. benchmarking: Perfomance to industry peers

Financial

	Indo US Bio-Tech	Sheetal Universal	Nath Bio-Genes
Operational Metrics
Financials
5 yr Average ROE	17.08 %	14.18 %	5.32 %
5yr average Equity Multiplier	1.63	2.79	1.7
5yr Average Asset Turnover Ratio	0.98	2.81	0.47
5yr Avg Net Profit Margin	11.14 %	2.68 %	3.69 %
Price to Book	3.16	6.23	0.39
P/E	18.47	29.31	6.17
5yr Avg Cash Conversion Cycle	-322.69 Days	111.03 Days	624.86 Days
Inventory Days	144.07 Days	26.24 Days	233.68 Days
Days Receivable	59.84 Days	76.36 Days	91.63 Days
Days Payable	195.14 Days	13.75 Days	-735.53 Days
5yr Average Interest Coverage Ratio	6.57	3.65	2.84
5yr Avg ROCE	18.82 %	19.76 %	11.39 %
5yr Avg Operating Profit Margin	13.97 %	3.33 %	14.56 %
5 yr average Debt to Equity	0.36	1.34	0.21
5yr CAGR Net Profit	45.1 %	106.11 %	26.86 %
5yr Average Return on Assets	10.87 %	5.62 %	2.21 %
Shareholdings
Promoter Holding	70.17 %	66.81 %	45.6 %
Share Pledged by Promoters	0.0	0.0	13.78 %
Change in Promoter Holding (3 Yrs)	0.0	0.0	0.0
Change in Mutual Fund Holding (3 Yrs)	0.0	0.0	-4.61 %

	Indo US Bio-Tech	Sheetal Universal	Nath Bio-Genes
Product Wise Break-Up	Product Wise Break-Up Vegetable Seeds 0 Plant Nutrient Suplement 0 Foundation Seeds 0 Commercial Seeds 0 Others 100	Product Wise Break-Up Commercial Seeds 0 Vegetable Seeds 0 Foundation Seeds 0 Plant Nutrient Suplement 0 Others 100	Product Wise Break-Up Commercial Seeds 86.98 Vegetable Seeds 2.45 Foundation Seeds 0 Plant Nutrients 10.05 Others 0.52